Cell‐free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just‐add‐water cell‐free system ASM Salehi, MT Smith, AM Bennett, JB Williams, WG Pitt, BC Bundy Biotechnology journal 11 (2), 274-281, 2016 | 157 | 2016 |
Reengineering viruses and virus-like particles through chemical functionalization strategies MT Smith, AK Hawes, BC Bundy Current opinion in biotechnology 24 (4), 620-626, 2013 | 145 | 2013 |
Lyophilized Escherichia coli-based cell-free systems for robust, high-density, long-term storage MT Smith, SD Berkheimer, CJ Werner, BC Bundy BioTechniques 56 (4), 186-193, 2014 | 122 | 2014 |
The emerging age of cell-free synthetic biology MT Smith, KM Wilding, JM Hunt, AM Bennett, BC Bundy FEBS letters 588 (17), 2755-2761, 2014 | 99 | 2014 |
Cell-Free Protein Synthesis Approach to Biosensing hTRβ-Specific Endocrine Disruptors ASM Salehi, MJ Shakalli Tang, MT Smith, JM Hunt, RA Law, DW Wood, ... Analytical Chemistry 89 (6), 3395-3401, 2017 | 93 | 2017 |
Biosensing estrogenic endocrine disruptors in human blood and urine: A RAPID cell-free protein synthesis approach ASM Salehi, SO Yang, CC Earl, MJS Tang, JP Hunt, MT Smith, DW Wood, ... Toxicology and applied pharmacology 345, 19-25, 2018 | 69 | 2018 |
The incorporation of the A2 protein to produce novel Qβ virus‐like particles using cell‐free protein synthesis MT Smith, CT Varner, DB Bush, BC Bundy Biotechnology progress 28 (2), 549-555, 2012 | 65 | 2012 |
Enhanced protein stability through minimally invasive, direct, covalent, and site‐specific immobilization MT Smith, JC Wu, CT Varner, BC Bundy Biotechnology progress 29 (1), 247-254, 2013 | 62 | 2013 |
Foot-and-mouth disease: Technical and political challenges to eradication MT Smith, AM Bennett, MJ Grubman, BC Bundy Vaccine 32 (31), 3902-3908, 2014 | 55 | 2014 |
Cell-free unnatural amino acid incorporation with alternative energy systems and linear expression templates P Shrestha, MT Smith, BC Bundy New biotechnology 31 (1), 28-34, 2014 | 55 | 2014 |
Creating a completely “cell‐free” system for protein synthesis MT Smith, AM Bennett, JM Hunt, BC Bundy Biotechnology progress 31 (6), 1716-1719, 2015 | 49 | 2015 |
Alternative fermentation conditions for improved Escherichia coli-based cell-free protein synthesis for proteins requiring supplemental components for proper synthesis MT Smith, AK Hawes, P Shrestha, JM Rainsdon, JC Wu, BC Bundy Process Biochemistry 49 (2), 217-222, 2014 | 37 | 2014 |
Beyond Heuristics: CFD‐Based Novel Multi‐Parameter Scale‐Up For Geometrically Disparate Bioreactors Demonstrated At Industrial 2kL ‐ 10kL Scales J Scully, LB Considine, MT Smith, E McAlea, N Jones, E O'Connell, ... Biotechnology and Bioengineering, 2020 | 34 | 2020 |
Polyvinylsulfonic acid: A Low-cost RNase inhibitor for enhanced RNA preservation and cell-free protein translation CC Earl, MT Smith, RA Lease, BC Bundy Bioengineered, 2017 | 25 | 2017 |
Efficient tRNA Degradation and Quantification in Escherichia Coli Cell Extract Using RNase‐Coated Magnetic Beads: A Key Step Towards Codon Emancipation ASM Salehi, MT Smith, SM Schinn, JM Hunt, C Muhlestein, J Diray‐Arce, ... Biotechnology Progress, 2017 | 19 | 2017 |
Technical and economic considerations of cell culture harvest and clarification technologies WA Dryden, LM Larsen, DW Britt, MT Smith Biochemical Engineering Journal 167, 107892, 2021 | 10 | 2021 |
Transient thermal modeling of bioprocess equipment CM Cummings, H Wang, MT Smith International Journal of Heat and Mass Transfer 184, 122064, 2022 | 4 | 2022 |
Single-use bioreactors: Performance and Usability Considerations, Part 2 MT Smith, B Madsen, TW Hsiao, N Jones Bioprocess International, 2018 | 4 | 2018 |
Single-use bioreactors: performance and usability considerations–Part 1: performance for process control MT Smith, B Madsen, TW Hsiao, N Jones Bioprocess Int 16, 15-19, 2018 | 4 | 2018 |
Fluid mixing systems including helical mixing assembly with impeller attachment and methods of use N Jones, K Steven, B Mills, M Smith, D West US Patent 11,352,598, 2022 | 1 | 2022 |